CURRICULUM VITAE. 2009 Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi

Doç Dr Uğur SELEK 1 CURRICULUM VITAE Doç. Dr. Uğur SELEK Amerikan Hastanesi-M.D. Anderson Radyasyon Onkolojisi Merkezi Bölüm Başkanı Teksas Üniversitesi, M. D. Anderson Radyasyon Onkolojisi Öğretim Üyesi EĞITIM 1979-1984 Afyon Atatürk İlkokulu 1984-1991 Usak Anadolu Lisesi 1991-1997 Hacettepe Üniversitesi İngilizce Tıp Fakültesi (HÜTF) 1997-2001 HÜTF Radyasyon Onkolojisi Anabilim Dalı İhtisası 2001-2002 Klinik Fellow Yoğunluk Ayarlı ve 3-Boyutlu Konformal Radyoterapi Programı, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD 2002-2003 Klinik Fellow Yoğunluk Ayarlı ve Stereotaktik Radyoterapi Programı, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD 2003-2004 Uzman Doktor, HÜTF Radyasyon Onkolojisi Anabilim Dalı 2004-2005 Yard. Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı 2005-2006 Yedek Subay, GATA Radyasyon Onkolojisi Anabilim Dalı 2006-2008 Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı 2009- Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi AKADEMİK HAYAT 1997 Tıp Doktoru, HÜTF 1998 Educational Commission for Foreign Medical Graduates Certification 2001 Radyasyon Onkolojisi Uzmanı, HÜTF 2001-3 Klinik Fellow, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD 2006 Doçent Doktor, HÜTF 2009 Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi

Doç Dr Uğur SELEK 2 ÖDÜL 2003 First Annual M. D. Anderson Radiation Oncology Fellow Research Award, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD ÜYELIKLER 1- ASTRO 2- EORTC 3- Türk Radyasyon Onkolojisi Derneği 4- Türk Akciğer Kanseri Derneği 5- M. D. Anderson Cancer Center Alumni and Faculty Association ULUSLARARASI KONGRE GÖREV VE HAKEMLİKLERİ 1. 2009 American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi, Şikago, ABD, Kasım 1-5: Poster Tartışması Moderatörü 2. 2009 American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi, Şikago, ABD, Kasım 1-5: Bildiri Hakemi 3. 2008 American Society of Radiation Oncology (ASTRO), 50. Yıllık Kongresi, Boston, ABD, Eylül 21-25: Bildiri Hakemi ULUSLARARASI DERGİ HAKEMLİKLERİ 1. International Journal of Radiation Oncology Biology Physics (ISSN: 0360-3016) 2. Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck (ISSN: 1043-3074) 3. Journal of Experimental & Clinical Cancer Research (ISSN: 1756-9966) 4. Tohoku Journal Of Experimental Medicine (ISSN: 0040-8727) 5. Journal of Palliative Medicine (ISSN: 1096-6218) 6. Journal of the National Medical Association (ISSN: 0027-9684) 7. Uluslararası Hematoloji-Onkoloji Dergisi (ISSN: 1306-133X) 8. Turkiye Klinikleri Tıp Bilimleri Dergisi (ISSN: 1300-0292) YAYINLAR Uluslararası Kitap Bölümleri 1. Selek U, Chang EL. Skull base and posterior fossa. In: Chao KSC, Ozyigit O, Apisarnthanarax S, editors. Practical essentials of Intensity Modulated Radiation Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. pp. 82-104 2. Ozyigit G, Selek U. Oral cavity. In: Chao KSC, Ozyigit O, Apisarnthanarax S, editors. Practical essentials of Intensity Modulated Radiation Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. pp. 153-165. Science Citation Index Expanded Yayınları

Doç Dr Uğur SELEK 3 1- Zorlu F, Selek U, Kiratli H. Initial Results Of Fractionated Cyberknife Radiosurgery For Uveal Melanoma. J Neurooncol. 2009 Feb 22. [Epub ahead of print] 2- Topkan E, Yildirim BA, Selek U, Yavuz MN. Cranial Prophylactic Irradiation in Locally Advanced Non-Small Cell Lung Carcinoma: Current Status and Future Perspectives. Oncology. 2009;76(3):220-8. Epub 2009 Feb 13. 3- Zorlu AF, Selek U, Emri S, Gurkaynak M, Akyol FH. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Yonsei Med J. 2008 Aug 30;49(4):620-4. 4- Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G, Altundag K. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc. 2008 May;100(5):521-6. 5- Atahan IL, Ozyigit G, Yildiz F, Gurkaynak M, Selek U, Sari S, Hayran M. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy. Breast J. 2008 May-Jun;14(3):245-9. Epub 2008 Apr 21. 6- Gultekin M, Selek U, Ozyigit G, Cengiz M, Yavas O, Yildiz F. Boost dose back again in elderly. J Clin Oncol. 2007 Dec 20;25(36):5843-4; author reply 5844-5. 7- Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncol. 2008;47(2):232-8. 8- Cengiz M, Yildiz F, Selek U, Ozyigit G. Comment on "computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachtherapy: results of a prospective trial and preliminary guidelines for standardized contours" by Viswanathan et Al. (Int j radiat oncol biol phys 2007;68:491-498, 2007). Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):963; author reply 963-4. 9- Yazici G, Selek U, Yildiz F, Ozyigit G, Cengiz M. Is mastectomy superior to breast-conserving treatment for young women? In regard to Coulombe et Al. (Int j radiat oncol biol phys 2007;67:1282-1290). Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):640; author reply 640.

Doç Dr Uğur SELEK 4 10- Cengiz M, Gürdalli S, Selek U, Yildiz F, Saglam Y, Ozyar E, Atahan IL. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):464-8. Epub 2007 Sep 4. 11- Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on "Cranial location of level II lymph nodes in laryngeal cancer: implications for elective nodal target volume delineation": in regard to Braam et al. (Int J Radiat Oncol Biol Phys 2007;67:462-468). Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1582-3; author reply 1583. 12- Selek U, Zorlu F, Hurmuz P, Cengiz M, Turker A, Soylemezoglu F, Gurkaynak M. Craniospinal radiotherapy in adult medulloblastoma. Strahlenther Onkol. 2007 May;183(5):236-40. 13- Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):833-42. Epub 2007 Mar 15. 14- Varan A, Akyüz C, Akalan N, Atahan L, Söylemezoglu F, Selek U, Yalçin B, Kutluk T, Büyükpamukçu M. Astrocytic tumors in children: treatment results from a single institution. Childs Nerv Syst. 2007 Mar;23(3):315-9. Epub 2006 Oct 13. 15- Cengiz M, Cetin E, Yildiz F, Selek U, Aydinkarahaliloglu E. Change in blood chemistry may explain higher toxicity of total body irradiation for bone marrow transplantation. Med Hypotheses. 2007;68(3):554-7. Epub 2006 Oct 2. 16- Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol. 2006 Oct;81(1):39-46. Epub 2006 Sep 11. 17- Yildiz F, Genc M, Akyurek S, Cengiz M, Ozyar E, Selek U, Atahan IL. Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc. 2006 Jul;98(7):1136-9. 18- Akyol F, Selek U, Ozyigit G, Onal C, Akdogan B, Karabulut E, Ozen H. Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. J Natl Med Assoc. 2006 Jul;98(7):1058-61.

Doç Dr Uğur SELEK 5 19- Yazici G, Yildiz F, Cengiz M, Ozyigit G, Selek U, Genç M, Atahan IL. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys 2006;64:205-209). Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1594; author reply 1594. 20- Cağlar K, Varan A, Akyüz C, Selek U, Kutluk T, Yalçin B, Atahan IL, Büyükpamukçu M. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol. 2006 Jun;28(6):374-8. 21- Atahan L, Yildiz F, Selek U, Sari S, Gurkaynak M. Postoperative radiotherapy in the treatment of male breast carcinoma: a single institute experience. J Natl Med Assoc. 2006 Apr;98(4):559-63. 22- Zorlu F, Selek U, Onal C, Söylemezoğlu F, Gurkaynak M. Postoperative radiotherapy in cranial ganglioglioma. J Neurooncol. 2006 May;77(3):321-4. 23- Zorlu F, Selek U, Soylemezoglu F, Oge K. Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone. J Neurooncol. 2006 Jan;76(2):149-52. 24- Zorlu F, Selek U, Akyuz C, Ozturk A, Soylemezoglu F, Akalan N. Spinal seeding of a pilocytic astrocytoma following multiple subtotal resections. Pediatr Neurosurg. 2005 Sep-Oct;41(5):248-52. 25- Zorlu F, Selek U, Ulger S, Donmez T, Erden E. Paraganglioma in sella. J Neurooncol. 2005 Jul;73(3):265-7. 26- Akyol F, Ozyigit G, Selek U, Karabulut E. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol. 2005 Jul;48(1):40-5. 27- Selek U, Cengiz M, Ozyigit G, Yildiz F, Lale Atahan I. Comment on: "HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome" [Radiother Oncol 2005;74:31-35, Shrivastava et al.]. Radiother Oncol. 2005 Jul;76(1):107-8; author reply 108. 28- Cengiz M, Selek U, Genç M, Aydinkarahaliloglu E, Yildiz F. Comment on "Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and histopathologic findings in 33 patients with operable cervix carcinoma". Radiother Oncol. 2005 Jun;75(3):367-8; author reply 368-9.

Doç Dr Uğur SELEK 6 29- Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005 May;56(5):936-45; discussion 936-45. 30- Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on: "Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy" Wu et al. [Radiother Oncol 2004; 71:201-206]. Radiother Oncol. 2005 Jan;74(1):78; author reply 78-9. 31- Cengiz M, Selek U, Yildiz F, Sari S. Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced nonsmall cell lung cancer: a clinical Phase II trial" Radiother Oncol 71(2):157-162, 2004 by Dr Chen et al.]. Radiother Oncol. 2005 Jan;74(1):76-7; author reply 77-8. 32- Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL. Treatment results of 59 young patients with nasopharyngeal carcinoma. Int J Pediatr Otorhinolaryngol. 2005 Feb;69(2):201-7. 33- Yildiz F, Kars A, Cengiz M, Yildiz O, Akyürek S, Selek U, Ozyigit G, Atahan IL. 1,25-Dihydroxy vitamin D3: can it be an effective therapeutic option for aggressive fibromatosis. Med Hypotheses. 2005;64(2):333-6. 34- Rosenthal DI, Barker JL Jr, El-Naggar AK, Glisson BS, Kies MS, Diaz EM Jr, Clayman GL, Demonte F, Selek U, Morrison WH, Ang KK, Chao KS, Garden AS. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer. 2004 Dec 1;101(11):2567-73. 35- Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106. 36- Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1039-46. 37- Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):743-51.

Doç Dr Uğur SELEK 7 38- Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F. Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol. 2004 Apr;71(1):85-90. 39- Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH. Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer. 2004 Apr 1;100(7):1491-7. Review. 40- Selek U, Lee A, Levy L, Kuban DA. Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):963-7.